Many consumer devices undergo the FDA clearance process, such as LED masks and fitness trackers that have features like ...
The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), a global leader in allogeneic cellular medicines for inflammatory diseases, today ...
In the U.S., it’s still found in many confections, including Sour Patch Kids watermelon candies, Hostess chocolate cupcakes ...
Going forward, we may see more instances in which insurers deny or (temporarily) severely restrict coverage of accelerated ...
8d
GlobalData on MSNSupernus wins FDA approval for Parkinson’s pump on fourth trySupernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...
The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...
Kexing Biopharm Co., Ltd. (Stock Code: 688136.SH) recently announced that the Investigational New Drug Application (IND) of GB05, Human Interferon α1b Inhalation Solution, a self-developed product by ...
Food & Wine on MSN8d
Are Natural Food Dyes Better? Experts Weigh In on the Pros and ConsNow that the U.S. Food and Drug Administration has banned Red Dye No. 3, artificial food dyes are under increasing scrutiny.
11d
Stockhead on MSNDr Boreham’s Crucible: FDA approval blasted this regenerative biotech higher in 2024… so what’s next?Fresh from FDA approval for its paediatric stem-cell product, Mesoblast is pursuing consent for indications of heart disease ...
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger travelers.On track for commercial launch in the U.S. in the ...
In the absence of strong state and federal regulations, some suburbs have banned the sale of hemp products that get users ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results